British health officials are beginning an immunization program designed to prevent infants and young children from contacting meningitis and septicemia.
A vaccine to prevent penumococcal disease will now be given to infants at 2, 4 and 13 months as part of regular immunizations, the London Telegraph reports.
In addition to killing 20 percent of its victims, pneumococcal disease can cause brain damage, deafness and epilepsy in those who survive.
Of the 530 cases recorded in England and Wales last year, 150 to 200 were infants under the age of two.
Symptoms of meningitis include stiff neck, extreme drowsiness and lack of appetite.
For infants a high-pitched cry and not wanting to be handled may also be evidence of the illness.
Copyright 2006 by United Press International
Related stories:
New insights could lead to a better pneumococcal vaccine
Discovery of a new, previously unknown mechanism of immunity suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at Children's Hospital Boston and Harvard School of Public Health (HSPH). The findings, published in the open-access journal
PLoS Pathogens on September 19, may aid the development of novel pneumococcal vaccines. (The current vaccine, Prevnar, is expensive and covers only 7 of the 91 known pneumococcal strains.)
Vaccinated infants well-protected against severe pneumococcal infection in Norway
In 2006, a pneumococcal vaccine (Prevenar®) was introduced in the childhood vaccination programme in Norway. Two years later, the experiences have been published in the journal
Vaccine. The results show a strong decline in serious pneumococcal infections among young children.
Effects of meningitis C jab may wear off
One in five 11–13 year olds appear to have low antibodies against meningitis C after being immunised as young children, suggests an Oxford University study published in the British Medical Journal.
Incidence of group B strep has decreased among newborns, but has increased among adults
Group B streptococcus, a major cause of serious infections, declined about 25 percent among infants younger than 7 days from 1999 to 2005, but increased nearly 50 percent among persons 15 to 64 years old, according to a study in the May 7 issue of JAMA.
Newer meningitis vaccine appears safe and effective for infants
A vaccine not yet licensed in the United States produces immunity against four strains of meningococcal disease and is well tolerated when administered to infants, according to a study in the January 9/16 issue of JAMA.
Bacterial infections in premature babies more common than previously realized
Premature babies are subject to a host of threats that can result in fetal/neonatal disease. In a study published in the January 2008 issue of the American Journal of Obstetrics & Gynecology, researchers from the University of Alabama–Birmingham Medical School and the Drexel University College of Medicine found that genital mycoplasmas are a frequent cause of congenital fetal infection. 23% of neonates born between 23 and 32 weeks of gestation have positive umbilical blood cultures for two genital mycoplasmas (bacteria lacking cell walls): Ureaplasma urealyticum and Mycoplasma hominis.
Shuttle brings space-grown strep bacteria back for study
When the space shuttle Endeavour touched down at the Kennedy Space Center August 21, University of Texas Medical Branch at Galveston microbiology and immunology department chairman David Niesel was waiting by the runway, looking forward to a reunion with some of its passengers.
States ask baby product companies to avoid BPA
(AP) -- Attorneys general from Connecticut, New Jersey and Delaware sent letters Friday to 11 companies that make baby bottles and baby formula containers, asking they no longer use the chemical bisphenol A in their manufacturing because they said it was potentially harmful to infants.